Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For Commercial Distribution In Europe, USA, Among Others
19/09/2022 02:37
Sept 19 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* SCENESSE IS APPROVED FOR COMMERCIAL DISTRIBUTION IN
EUROPE, USA,
ISRAEL AND AUSTRALIA
Source text for Eikon: ID:nASX7kFlvZ
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist